Related Experiment Video
Updated: May 21, 2026
09:07
Rapid Isolation of BMPR-IB+ Adipose-Derived Stromal Cells for Use in a Calvarial Defect Healing Model
Published on: February 24, 2017
BMP-6 is more efficient in bone formation than BMP-2 when overexpressed in mesenchymal stem cells
O Mizrahi1, D Sheyn, W Tawackoli
1Skeletal Biotech Laboratory, Hebrew University-Hadassah, Faculty of Dental Medicine, Jerusalem, Israel.
Gene Therapy
|June 22, 2012
Summary
Bone marrow mesenchymal stem cells (BMSCs) nucleofected with rhBMP-6 show superior bone regeneration potential compared to adipose stem cells (ASCs) or rhBMP-2. This finding advances nonviral gene therapy for fracture healing.
Area of Science:
- Regenerative Medicine
- Biotechnology
- Orthopedic Research
Background:
- Mesenchymal stem cells (MSCs) and nonviral gene therapy offer promise for healing difficult fractures.
- Overexpressing bone morphogenetic proteins (BMPs) in MSCs can induce osteogenic differentiation and bone formation.
Purpose of the Study:
- To evaluate osteogenic differentiation potential of porcine adipose tissue-derived MSCs (ASCs) and bone marrow-derived MSCs (BMSCs).
- To compare the efficacy of nucleofection with rhBMP-2 versus rhBMP-6 in inducing bone regeneration in vitro and in vivo.
Main Methods:
- Porcine ASCs and BMSCs were nucleofected with rhBMP-2 or rhBMP-6.
- Osteogenic differentiation was assessed in vitro.
- In vivo bone regeneration was quantified using micro-computed tomography (micro-CT).
Main Results:
- Nucleofection efficiency and cell viability were comparable between ASCs and BMSCs.
- Micro-CT analysis revealed that rhBMP-6 induced faster bone formation and larger bone volumes than rhBMP-2 in both cell types.
- RhBMP-6 promoted more efficient in vitro osteogenic differentiation in BMSCs.
Conclusions:
- Bone marrow-derived MSCs exhibit greater osteogenic potential than ASCs, both in vitro and in vivo.
- BMSCs nucleofected with rhBMP-6 demonstrated superior in vivo bone formation compared to all other experimental groups.
